Lino Biotech
Key Facts
| Invested since | 2020 |
| Based in | Zurich |
About the company
lino Biotech AG was incorporated as a ETH Zurich spin-out in Zürich, Switzerland, in March 2020, and is venture backed by Roche Venture Fund, High-Tech Gründerfonds and several lifescience family offices. lino offers industry partners and researchers a unique way to study molecular interactions in living cells and crude biosystems.
Do you want to
know more about this company?
Lino Biotech in the news
zum Artikel
lino Biotech closes seed financing round and showcases a novel label-free biosensor platform for innovate modern drug screening
More startups from Life Sciences
Exit
Capical is the world leading company for contact-free ECG-measurement via capacitive electrodes. The main application areas are drivers state monitoring for the automotive industry and contact-free cardiac monitoring solutions for …
to Capical
Exit
First-in-class Entry-Inhibitor for the treatment of chronic hepatitis Delta
to MYR
Refoxy is the first biotech company purposely developing FOXO3 activators to leverage the therapeutic effects related to this master regulator of biological homeostasis. Refoxy’s discovery platform, F.act finder (FOXO activator …
to Refoxy Pharma
Exit
Amedrix develops & produces three dimensional implants (gel and liquid) based on collagen. Focus: treatment of articular cartilage damage in human an horse and other promising application areas. CE-mark for …
to Amedrix
Exit
Rigontec GmbH is a preclinical biotech company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases. Rigontec’s lead compound ImOl100 targets a novel receptor of the innate immune …
to Rigontec
Preventicus GmbH is developing smartphone-driven solutions to capture and analyze patients’ vital parameters for early preclinical risk screening of lifestyle-related illnesses. Seed funding for the Jena-based company is managed by …
to Preventicus
Exit
KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the …
to KSK Diagnostics
Exit
GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with …
to GQ Bio Therapeutics
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach …
to Thermosome
Smarterials Technology GmbH is a young MedTech company with high competence in the fields of inorganic chemistry, surface functionalization and process technology. The company was founded by two material scientists …
to Smarterials Technology
Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.
to Cryotherapeutics
Exit
iAtros is a digital heart clinic and a fully integrated platform, providing better medical care for patients with cardiovascular problems around the clock. Among other services, iATROS offers smart sensor …
to iATROS